Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan

Journal of Gastroenterology

Volumn 47, Issue 7, 2012, Pages 770-774

  Ono, Satoshi ^a   Fujishiro, Mitsuhiro ^a   Kodashima, Shinya ^a   Takahashi, Yu ^a   Minatsuki, Chihiro ^a   Mikami Matsuda, Rie ^a   Asada Hirayama, Itsuko ^a   Konno Shimizu, Maki ^a   Tsuji, Yosuke ^a   Mochizuki, Satoshi ^a   Niimi, Keiko ^a   Yamamichi, Nobutake ^a   Kaneko, Makoto ^a   Yatomi, Yutaka ^a   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antithrombotic agent; Biopsy; Bleeding; Colonoscopy; Complication; Esophagogastroduodenoscopy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CILOSTAZOL; CLOPIDOGREL; HISTAMINE H2 RECEPTOR ANTAGONIST; ICOSAPENTATE; PROSTAGLANDIN DERIVATIVE; PROTON PUMP INHIBITOR; SARPOGRELATE; SEROTONIN ANTAGONIST; TICLOPIDINE; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; BLEEDING TIME; CLINICAL OBSERVATION; CLINICAL TRIAL; COLONOSCOPY; CORONARY STENT; DRUG WITHDRAWAL; ENDOSCOPIC BIOPSY; ENDOSCOPIC BLEEDING TIME; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE REPLACEMENT; HEMOSTASIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; THROMBOEMBOLISM; WESTERN HEMISPHERE;

AGED; AGED, 80 AND OVER; BIOPSY; COLONOSCOPY; DRUG THERAPY, COMBINATION; ENDOSCOPY, DIGESTIVE SYSTEM; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOEMBOLISM; TIME FACTORS; WARFARIN;

EID: 84865014777     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0538-7     Document Type: Article

References (19)

1. Kodashima S, Fujishiro M. Novel image-enhanced endoscopy with i-scan technology. World J Gastroenterol. 2010;16:1043-9.
2. Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc. 2004;59:288-95.
3. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308:81-106.
4. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
5. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
6. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-60.
7. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995;310:827-30.
8. Sorensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol. 2000;95:2218-24.
9. Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 2006;333:726.
10. Aronow HD, Steinhubl SR, Brennan DM, Berger PB, Topol EJ. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J. 2009;157:369-74.
11. Napoleon B, Boneu B, Maillard L, Samama CM, Schved JF, Gay G, et al. Guidelines of the French Society for Digestive Endoscopy (SFED). Endoscopy. 2006;38:632-8.
12. Lee SY, Tang SJ, Rockey DC, Weinstein D, Lara L, Sreenarasimhaiah J, et al. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc. 2008;67:1076-81.
13. Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57:1322-9.
14. Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009;70:1060-70.
15. Hori M, Ikeda Y, Ishimaru S, Inoue H, Uchiyama S, Ogawa H, et al. Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2009). 2009, published only online. http://wwwj-circorjp/guideline/pdf/JCS2009-hori-dpdf (Japanese).
16. Ogoshi K, Kaneko E, Tada M, MIne T, Yoshino J, Yahagi N, et al. The management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastroenterol Endosc. 2005;47:2691-5.
17. Fujishiro M, Oda I, Yamamoto Y, Akiyama J, Ishii N, Kakushima N, et al. Multi-center survey regarding the management of anticoagulation and antiplatelet therapy for endoscopic procedures in Japan. J Gastroenterol Hepatol. 2009;24:214-8.
18. Ono S, Fujishiro M, Kanzaki H, Uedo N, Yokoi C, Akiyama J, et al. Conflicting clinical environment about the management of antithrombotic agents during the periendoscopic period in Japan. J Gastroenterol Hepatol. 2011.
19. Li Y, Sha W, Nie Y, Wu H, She Q, Dai S, et al. Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterol Hepatol. 2000;15:148-54.